Enrolling By Invitation PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT04357600

Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B

Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B: Phase I/ II Study

Sponsor: PT. Prodia Stem Cell Indonesia

Interventions Allogeneic Umbilical Cord Mesenchymal Stem Cell

Updated 8 times since 2020 Last updated: Feb 23, 2026 Started: May 17, 2018 Primary completion: Jun 20, 2027 Completion: Dec 20, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Liver Cirrhoses, this trial is ongoing. The trial is conducted by PT. Prodia Stem Cell Indonesia and has accumulated 8 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Feb 2026 — Present [monthly]

Enrolling By Invitation PHASE1/PHASE2

Status: Unknown → Enrolling By Invitation
Sep 2024 — Feb 2026 [monthly]

Unknown PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1/PHASE2

Status: Recruiting → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jul 2022 — Jul 2024 [monthly]

Recruiting PHASE1_PHASE2

Status: Unknown Status → Recruiting
Apr 2022 — Jul 2022 [monthly]

Unknown Status PHASE1_PHASE2

Status: Recruiting → Unknown Status

▶ Show 3 earlier versions

Jan 2021 — Apr 2022 [monthly]

Recruiting PHASE1_PHASE2
Jul 2020 — Jan 2021 [monthly]

Recruiting PHASE1_PHASE2
May 2020 — Jul 2020 [monthly]

Recruiting PHASE1_PHASE2

First recorded

May 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

PT. Prodia Stem Cell Indonesia

Data source: PT. Prodia Stem Cell Indonesia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jakarta, Indonesia